It is notable that some miRNAs regulating CELF have the same profile of expression in different cancer types in response to different drugs, as in the case of miR-106, others vary according to the tested drug in the same cancer type (miR-210), and, in a third scenario, there are miRNAs that are differentially expressed in the treated group and not in the control group. The gene discussed is CEBPD; the disease is cancer.